Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, Saitama 351-0198, Japan.
Hum Mol Genet. 2010 Jun 1;19(11):2099-112. doi: 10.1093/hmg/ddq087. Epub 2010 Feb 25.
In polyglutamine diseases including Huntington's disease (HD), mutant proteins containing expanded polyglutamine stretches form nuclear aggregates in neurons. Although analysis of their disease models suggested a significance of transcriptional dysregulation in these diseases, how it mediates the specific neuronal cell dysfunction remains obscure. Here we performed a comprehensive analysis of altered DNA binding of multiple transcription factors using R6/2 HD model mice brains that express an N-terminal fragment of mutant huntingtin (mutant Nhtt). We found a reduction of DNA binding of Brn-2, a POU domain transcription factor involved in differentiation and function of hypothalamic neurosecretory neurons. We provide evidence supporting that Brn-2 loses its function through two pathways, its sequestration by mutant Nhtt and its reduced transcription, leading to reduced expression of hypothalamic neuropeptides. In contrast to Brn-2, its functionally related protein, Brn-1, was not sequestered by mutant Nhtt but was upregulated in R6/2 brain, except in hypothalamus. Our data indicate that functional suppression of Brn-2 together with a region-specific lack of compensation by Brn-1 mediates hypothalamic cell dysfunction by mutant Nhtt.
在包括亨廷顿病(HD)在内的多聚谷氨酰胺疾病中,含有扩展多聚谷氨酰胺链的突变蛋白在神经元中形成核聚集体。尽管对这些疾病模型的分析表明转录失调在这些疾病中具有重要意义,但它如何介导特定的神经元细胞功能障碍仍然不清楚。在这里,我们使用表达突变 huntingtin(mutant Nhtt)N 端片段的 R6/2 HD 模型小鼠大脑,对多个转录因子的改变 DNA 结合进行了全面分析。我们发现,参与下丘脑神经分泌神经元分化和功能的 POU 结构域转录因子 Brn-2 的 DNA 结合减少。我们提供的证据支持 Brn-2 通过两种途径失去其功能,即通过突变 Nhtt 隔离和转录减少,导致下丘脑神经肽表达减少。与 Brn-2 相反,其功能相关的蛋白质 Brn-1 没有被突变 Nhtt 隔离,但在 R6/2 大脑中上调,除了在下丘脑。我们的数据表明,突变 Nhtt 通过 Brn-2 的功能抑制以及 Brn-1 的区域特异性缺乏补偿来介导下丘脑细胞功能障碍。